The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: Comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis

Human Pathology

Volumn 41, Issue 8, 2010, Pages 1145-1149

  Quick, Charles M ^a   Gokden, Neriman ^a   Sangoi, Ankur R ^b   Brooks, James D ^b   McKenney, Jesse K ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Central zone; Ejaculatory duct; PAX 2; Prostate; Seminal vesicle

Indexed keywords

TRANSCRIPTION FACTOR PAX2; PAX2 PROTEIN, HUMAN;

ARTICLE; BULBOURETHRAL GLAND; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EJACULATORY DUCT; EMBRYO DEVELOPMENT; EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NEEDLE BIOPSY; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; SEMINAL VESICLE; STAINING; TISSUE MICROARRAY; ADENOCARCINOMA; METABOLISM; PATHOLOGY; PRENATAL DEVELOPMENT; PROSTATE TUMOR;

ADENOCARCINOMA; EJACULATORY DUCTS; HUMANS; MALE; PAX2 TRANSCRIPTION FACTOR; PROSTATE; PROSTATIC NEOPLASMS; SEMINAL VESICLES;

EID: 77955072053     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.01.010     Document Type: Article

References (24)

1. Srigley J.R. Benign mimickers of prostatic adenocarcinoma Mod Pathol 17 2004 328 348
2. Coyne J.D., Kealy W.F., and Annis P. Seminal vesicle epithelium in prostatic needle biopsy specimens J Clin Pathol 40 1987 932
3. Amin M.B., and Bostwick D.G. Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium Mod Pathol 9 1996 791 795
4. Brennick J.B., O'Connell J.X., Dickersin G.R., Pilch B.Z., and Young R.H. Lipofuscin pigmentation (so-called "melanosis") of the prostate Am J Surg Pathol 18 1994 446 454
5. Parwani A.V., Herawi M., and Epstein J.I. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases Am J Surg Pathol 30 2006 1254 1259
6. Davies J.A., Perera A.D., and Walker C.L. Mechanisms of epithelial development and neoplasia in the metanephric kidney Int J Dev Biol 43 1999 473 478
7. Dressler G.R., Deutsch U., Chowdhury K., Nornes H.O., and Gruss P. Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system Development 109 1990 787 795
8. Rothenpieler U.W., and Dressler G.R. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development Development 119 1993 711 720
9. Torres M., Gomez-Pardo E., Dressler G.R., and Gruss P. Pax-2 controls multiple steps of urogenital development Development 121 1995 4057 4065
10. Daniel L., Lechevallier E., and Giorgi R. Pax-2 expression in adult renal tumors Hum Pathol 32 2001 282 287
11. Gnarra J.R., and Dressler G.R. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides Cancer Res 55 1995 4092 4098
12. Gokden N., Gokden M., Phan D.C., and McKenney J.K. The utility of PAX-2 in distinguishing metastatic renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker Am J Surg Pathol 32 2008 1462 1467
13. Gokden N., Kemp S.A., and Gokden M. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology Diagn Cytopathol 36 2008 473 477
14. Mazal P.R., Stichenwirth M., and Koller A. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study Mod Pathol 18 2005 535 540
15. Tong G.X., Melamed J., and Mansukhani M. PAX2: a reliable marker for nephrogenic adenoma Mod Pathol 19 2006 356 363
16. Leroy X., Ballereau C., and Villers A. MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinoma Am J Surg Pathol 27 2003 519 521
17. Shidham V.B., Lindholm P.F., and Kajdacsy-Balla A. Prostate-specific antigen expression and lipochrome pigment granules in the differential diagnosis of prostatic adenocarcinoma versus seminal vesicle-ejaculatory duct epithelium Arch Pathol Lab Med 123 1999 1093 1097
18. Varma M., Morgan M., O'Rourke D., and Jasani B. Prostate specific antigen (PSA) and prostate specific acid phosphatase (PSAP) immunoreactivity in benign seminal vesicle\ejaculatory duct epithelium: a potential pitfall in the diagnosis of prostate cancer in needle biopsy specimens Histopathology 44 2004 405 406
19. Dressler G.R. Pax-2, kidney development, and oncogenesis Med Pediatr Oncol 27 1996 440 444
20. Eccles M.R., He S., and Legge M. PAX genes in development and disease: the role of PAX2 in urogenital tract development Int J Dev Biol 46 2002 535 544
21. Tong G.X., Chiriboga L., Hamele-Bena D., and Borczuk A.C. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary mullerian system origin? Mod Pathol 20 2007 856 863
22. Argani P., Walsh P.C., and Epstein J.I. Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures: further evidence of the mesodermal origin of the prostatic central zone J Urol 160 6 Pt 1 1998 2126 2129
23. Cunha G.R., and Donjacour A.A. Mesenchymal-epithelial interactions in the growth development of the prostate H. Lepor, T.L. Ratliff, Urologic oncology, vol 1989 Kluwer Academic Boston 159 175
24. McNeal J.E. Developmental and comparative anatomy of the prostate J. Grayhack, J. Wilson, M. Scherbenske, Benign prostatic hyperplasia. DHEW publication no. (NIH) 76-1113., Vol 1975 Department of Health, Education, and Welfare Washington (DC) 1 10